Medexus Pharmaceuticals (TSE:MDP) Stock Price Down 2.2% – Time to Sell?

Medexus Pharmaceuticals Inc. (TSE:MDP) traded down 2.2% on Friday . The company traded as low as C$3.07 and last traded at C$3.08. 12,802 shares changed hands during mid-day trading, a decline of 73% from the average session volume of 46,873 shares. The stock had previously closed at C$3.15.

Medexus Pharmaceuticals Price Performance

The firm has a market capitalization of C$99.48 million, a PE ratio of -154.00 and a beta of 0.68. The business’s 50-day moving average price is C$2.96 and its 200-day moving average price is C$2.86.

About Medexus Pharmaceuticals

Medexus Pharmaceuticals Inc, formerly Pediapharm Inc is a leading specialty pharmaceutical company with a strong North American commercial platform. It is focused on the therapeutic areas of auto-immune disease and pediatrics. The leading products are Rasuvo and Metoject, a unique formulation of methotrexate to treat rheumatoid arthritis and other auto-immune diseases; and Rupall, an innovative allergy medication with a unique mode of action.